<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">glaucoma</journal-id><journal-title-group><journal-title xml:lang="ru">Национальный журнал Глаукома</journal-title><trans-title-group xml:lang="en"><trans-title>National Journal glaucoma</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2078-4104</issn><issn pub-type="epub">2311-6862</issn><publisher><publisher-name>Federal State Budgetary Institution of Science “Krasnov Research Institute of Eye Diseases”</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.53432/2078-4104-2026-25-1-66-75</article-id><article-id custom-type="elpub" pub-id-type="custom">glaucoma-612</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ ЛИТЕРАТУРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>LITERATURE REVIEWS</subject></subj-group></article-categories><title-group><article-title>Особенности медикаментозного и хирургического лечения глаукомы низкого давления</article-title><trans-title-group xml:lang="en"><trans-title>Features of medical and surgical treatment of normal-tension glaucoma</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7735-9650</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Витков</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Vitkov</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Витков А.А., к.м.н., научный сотрудник отдела глаукомы</p><p>119021, Москва, ул. Россолимо, 11А</p></bio><bio xml:lang="en"><p>Vitkov A.A., Cand. Sci. (Med), researcher at the Glaucoma Department</p><p>11A Rossolimo St., Moscow, 1190214</p></bio><email xlink:type="simple">avitkov.niigb@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1175-3695</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Глазко</surname><given-names>Н. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Glazko</surname><given-names>N. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Глазко Н.Г., к.м.н., врач-офтальмолог</p><p>109472, Москва, Волгоградский пр-т, 168</p></bio><bio xml:lang="en"><p>Glazko N.G., Cand. Sci. (Med), ophthalmologist</p><p>168 Volgogradsky Prospekt, Moscow, 109472</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1148-5184</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бакунина</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Bakunina</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бакунина Н.А., д.м.н., доцент кафедры глазных болезней, врач-офтальмолог</p><p>117198, Москва, ул. Миклухо-Маклая, 6;</p><p>119049, Москва, Ленинский проспект, 8</p></bio><bio xml:lang="en"><p>Bakunina N.A., Dr. Sci. (Med.), Associate Professor at the Academic Department of Eye Diseases, ophthalmologist</p><p>6 Miklukho-Maklaya St., Moscow, 117198;</p><p>8 Leninskiy Prospekt, Moscow, 117049</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6321-8109</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Селезнев</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Seleznev</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Селезнев А.В., к.м.н., доцент кафедры оториноларингологии и офтальмологии</p><p>153012, Иваново, Шереметьевский проспект, 8</p></bio><bio xml:lang="en"><p>Seleznev A.V., Cand. Sci. (Med.), Assistant Professor at the Academic Department of Otorhinolaryngology and Ophthalmology</p><p>8 Sheremetevskii Prospekt, Ivanovo, 153012</p></bio><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5597-983X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Брежнев</surname><given-names>А. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Brezhnev</surname><given-names>A. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Брежнев А.Ю., к.м.н., доцент кафедры офтальмологии</p><p>305041, Курск, ул. Карла Маркса, 3</p></bio><bio xml:lang="en"><p>Brezhnev A.Yu., Cand. Sci. (Med.), Associate Professor at the Academic Department of Ophthalmology</p><p>3 Karla Marksa St., Kursk, 305041</p></bio><xref ref-type="aff" rid="aff-5"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9606-0566</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Куроедов</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kuroyedov</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Куроедов А.В., д.м.н., профессор, заведующий кафедрой офтальмологии, начальник офтальмологического центра (с дневным стационаром)</p><p>117997, Москва, ул. Островитянова, 1;</p><p>107014, Москва, ул. Б. Оленья, 8А</p></bio><bio xml:lang="en"><p>Kuroyedov A.V., Dr. Sci. (Med.), Professor, Head of the Academic Department of Ophthalmology, Head of the Ophthalmology Сenter</p><p>1 Ostrovityanova St., Moscow, 117997;</p><p>8A Bolshaya Olenya St., Moscow, 107014</p></bio><xref ref-type="aff" rid="aff-6"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ «Научно-исследовательский институт глазных болезней имени М.М. Краснова»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Krasnov Research Institute of Eye Diseases</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ГБУЗ «Госпиталь для ветеранов войн №2 ДЗМ»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Hospital for War Veterans No. 2 of the Moscow City Health Department</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГАОУ ВО «Российский университет дружбы народов имени Патриса Лумумбы»; ГБУЗ ГКБ №1 им. Н.И. Пирогова ДЗМ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Peoples' Friendship University of Russia named after Patrice Lumumba; Сity Clinical Hospital № 1</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>ФГБОУ ВО Ивановский ГМУ Минздрава РФ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Ivanovo State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-5"><aff xml:lang="ru"><institution>ФГБОУ ВО КГМУ Минздрава РФ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Kursk State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-6"><aff xml:lang="ru"><institution>ФГАОУ ВО «РНИМУ им. Н.И. Пирогова» Минздрава РФ; ФКУ «ЦВКГ им. П.В. Мандрыка» Минобороны РФ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Clinical Medicine of the Pirogov Russian National Research Medical University; Mandryka Central Military Clinical Hospital</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>18</day><month>03</month><year>2026</year></pub-date><volume>25</volume><issue>1</issue><fpage>66</fpage><lpage>75</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Витков А.А., Глазко Н.Г., Бакунина Н.А., Селезнев А.В., Брежнев А.Ю., Куроедов А.В., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Витков А.А., Глазко Н.Г., Бакунина Н.А., Селезнев А.В., Брежнев А.Ю., Куроедов А.В.</copyright-holder><copyright-holder xml:lang="en">Vitkov A.A., Glazko N.G., Bakunina N.A., Seleznev A.V., Brezhnev A.Y., Kuroyedov A.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.glaucomajournal.ru/jour/article/view/612">https://www.glaucomajournal.ru/jour/article/view/612</self-uri><abstract><p>Глаукома низкого давления представляет собой прогрессирующую оптиконейропатию, характеризующуюся истончением перипапиллярного слоя нервных волокон сетчатки с развитием характерных дефектов поля зрения, открытым углом передней камеры, а также уровнем внутриглазного давления, не выходящим за пределы статистически низкого диапазона. Течение данного заболевания отличается от гипертензивной глаукомы наличием локальных более глубоких дефектов светочувствительности, а также их большей скоростью прогрессирования.</p><p>Лечение глаукомы низкого давления (медикаментозное, лазерное или хирургическое) направлено на снижение уровня офтальмотонуса и достижение его целевых значений, при которых возможно остановить распад зрительных функций. Особенностью подхода к лечению данной разновидности глаукомы являются более низкие значения целевых показателей, что вместе с высокой скоростью прогрессирования требует более быстрого перехода к хирургическому лечению. Проблема глаукомы низкого давления заключается в особен-ностях диагностики, клинических проявлений и лечения, требующих дифференцированного и персонализированного подхода.</p><p>В обзоре проанализированы актуальные данные по морфофункциональным отличиям глаукомы низкого давления от первичной открытоугольной глаукомы, протекающей по обычному типу, исследована эффективность применения различных фармакологических групп медикаментозных гипотензивных средств, а также изучены современные тренды хирургического лечения данного заболевания.</p></abstract><trans-abstract xml:lang="en"><p>Normal-tension glaucoma is a progressive optic neuropathy characterized by thinning of the peripapillary retinal nerve fiber layer and the development of typical visual field defects, open anterior chamber angle, and intraocular pressure levels that do not exceed the statistically normal range. The course of this disease differs from that of hypertensive glaucoma by the presence of more localized and deeper defects of light sensitivity, as well as by a higher rate of progression.</p><p>The management of normal-tension glaucoma (medical, laser, or surgical) is aimed at reducing intraocular pressure and achieving target levels at which further loss of visual function can be halted. A distinctive feature of the therapeutic approach to this form of glaucoma is the need for lower target intraocular pressure values, which, in combination with the high rate of disease progression, necessitates a more rapid transition to surgical treatment. The challenge of normal-tension glaucoma lies in its diagnostic features, clinical manifestations, and treatment strategies, all of which require a differentiated and personalized approach.</p><p>This literature review analyzes current data on the morphological and functional differences between normaltension glaucoma and typical primary open-angle glaucoma, evaluates the effectiveness of various pharmacological classes of hypotensive medications, and examines modern trends in the surgical management of this disease.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>глаукома низкого давления</kwd><kwd>хирургия глаукомы</kwd><kwd>медикаментозная терапия</kwd><kwd>внутриглазное давление</kwd></kwd-group><kwd-group xml:lang="en"><kwd>glaucoma</kwd><kwd>normal-tension glaucoma surgery</kwd><kwd>pharmacotherapy</kwd><kwd>intraocular pressure</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Chen MJ. Normal tension glaucoma in Asia: Epidemiology, pathogenesis, diagnosis, and management. Taiwan J Ophthalmol 2020; 10(4):250-254. https://doi.org/10.4103/tjo.tjo_30_20.</mixed-citation><mixed-citation xml:lang="en">Chen MJ. Normal tension glaucoma in Asia: Epidemiology, pathogenesis, diagnosis, and management. Taiwan J Ophthalmol 2020; 10(4):250-254. https://doi.org/10.4103/tjo.tjo_30_20.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao J, Solano MM, Oldenburg CE, et al. Prevalence of normal-tension glaucoma in the Chinese population: A systematic review and meta-analysis. Am J Ophthalmol 2019; 199:101-110. https://doi.org/10.1016/j.ajo.2018.10.017.</mixed-citation><mixed-citation xml:lang="en">Zhao J, Solano MM, Oldenburg CE, et al. Prevalence of normal-tension glaucoma in the Chinese population: A systematic review and meta-analysis. Am J Ophthalmol 2019; 199:101-110. https://doi.org/10.1016/j.ajo.2018.10.017.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Петров С.Ю. Современный взгляд на глаукому низкого давления. Вестник офтальмологии 2020; 136(6):57-64. https://doi.org/10.17116/oftalma202013606157.</mixed-citation><mixed-citation xml:lang="en">Petrov S.Y. Modern view on normal-tension glaucoma. Russian Annals of Ophthalmology 2020; 136(6):57-64. https://doi.org/10.17116/oftalma202013606157.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">L.C. Gutiérrez Martín. Update on the diagnosis and treatment of normotensive glaucoma. Archivos de la Sociedad Española de Oftalmología (English Edition) 2023; 98(6):344-350. https://doi.org/10.1016/j.oftale.2023.05.004.</mixed-citation><mixed-citation xml:lang="en">L.C. Gutiérrez Martín. Update on the diagnosis and treatment of normotensive glaucoma. Archivos de la Sociedad Española de Oftalmología (English Edition) 2023; 98(6):344-350. https://doi.org/10.1016/j.oftale.2023.05.004.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Costagliola C, Agnifili L, Mastropasqua L, di Costanzo A. Low-Tension Glaucoma: An Oxymoron in Ophthalmology. Prev Chronic Dis 2019; 16:E10. https://doi.org/10.5888/pcd16.180534.</mixed-citation><mixed-citation xml:lang="en">Costagliola C, Agnifili L, Mastropasqua L, di Costanzo A. Low-Tension Glaucoma: An Oxymoron in Ophthalmology. Prev Chronic Dis 2019; 16:E10. https://doi.org/10.5888/pcd16.180534.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Traynis I, De Moraes CG, Raza AS, et al. Prevalence and nature of early glaucomatous defects in the central 10 degrees of the visual field. JAMA Ophthalmol 2014; 132(3):291-297. https://doi.org/10.1001/jamaophthalmol.2013.7656.</mixed-citation><mixed-citation xml:lang="en">Traynis I, De Moraes CG, Raza AS, et al. Prevalence and nature of early glaucomatous defects in the central 10 degrees of the visual field. JAMA Ophthalmol 2014; 132(3):291-297. https://doi.org/10.1001/jamaophthalmol.2013.7656.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Cho HK, Lee J, Lee M, Kee C. Initial central scotomas vs peripheral scotomas in normal-tension glaucoma: clinical characteristics and progression rates. Eye (Lond) 2014; 28(3):303-311. https://doi.org/10.1038/eye.2013.285.</mixed-citation><mixed-citation xml:lang="en">Cho HK, Lee J, Lee M, Kee C. Initial central scotomas vs peripheral scotomas in normal-tension glaucoma: clinical characteristics and progression rates. Eye (Lond) 2014; 28(3):303-311. https://doi.org/10.1038/eye.2013.285.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Kim KN, Jeoung JW, Park KH, et al. Relationship between preferred sleeping position and asymmetric visual field loss in open-angle glaucoma patients. Am J Ophthalmol 2014; 157(3):739-745. https://doi.org/10.1016/j.ajo.2013.12.016.</mixed-citation><mixed-citation xml:lang="en">Kim KN, Jeoung JW, Park KH, et al. Relationship between preferred sleeping position and asymmetric visual field loss in open-angle glaucoma patients. Am J Ophthalmol 2014; 157(3):739-745. https://doi.org/10.1016/j.ajo.2013.12.016.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Esporcatte BL, Tavares IM. Normal-tension glaucoma: an update. Arq Bras Oftalmol 2016; 79(4):270-276. https://doi.org/10.5935/0004-2749.20160077.</mixed-citation><mixed-citation xml:lang="en">Esporcatte BL, Tavares IM. Normal-tension glaucoma: an update. Arq Bras Oftalmol 2016; 79(4):270-276. https://doi.org/10.5935/0004-2749.20160077.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Adlina AR, Alisa-Victoria K, Shatriah I, et al. Optic disc topography in Malay patients with normal-tension glaucoma and primary openangle glaucoma. Clin Ophthalmol 2014; 8:2533-2539. https://doi.org/10.2147/OPTH.S71136.</mixed-citation><mixed-citation xml:lang="en">Adlina AR, Alisa-Victoria K, Shatriah I, et al. Optic disc topography in Malay patients with normal-tension glaucoma and primary openangle glaucoma. Clin Ophthalmol 2014; 8:2533-2539. https://doi.org/10.2147/OPTH.S71136.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Park HY, Lee KI, Lee K, et al. Torsion of the optic nerve head is a prominent feature of normal-tension glaucoma. Invest Ophthalmol Vis Sci 2014; 56(1):156-163. https://doi.org/10.1167/iovs.13-12327.</mixed-citation><mixed-citation xml:lang="en">Park HY, Lee KI, Lee K, et al. Torsion of the optic nerve head is a prominent feature of normal-tension glaucoma. Invest Ophthalmol Vis Sci 2014; 56(1):156-163. https://doi.org/10.1167/iovs.13-12327.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Mallick J, Devi L, Malik PK, Mallick J. Update on Normal Tension Glaucoma. J Ophthalmic Vis Res 2016; 11(2):204-248. https://doi.org/10.4103/2008-322X.183914.</mixed-citation><mixed-citation xml:lang="en">Mallick J, Devi L, Malik PK, Mallick J. Update on Normal Tension Glaucoma. J Ophthalmic Vis Res 2016; 11(2):204-248. https://doi.org/10.4103/2008-322X.183914.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Killer HE, Pircher A. Normal tension glaucoma: review of current understanding and mechanisms of the pathogenesis. Eye (Lond) 2018; 32(5):924-930. https://doi.org/10.1038/s41433-018-0042-2.</mixed-citation><mixed-citation xml:lang="en">Killer HE, Pircher A. Normal tension glaucoma: review of current understanding and mechanisms of the pathogenesis. Eye (Lond) 2018; 32(5):924-930. https://doi.org/10.1038/s41433-018-0042-2.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Furlanetto RL, De Moraes CG, Teng CC, et al. Low-Pressure Glaucoma Treatment Study Group. Risk factors for optic disc hemorrhage in the low-pressure glaucoma treatment study. Am J Ophthalmol 2014; 157(5):945-952. https://doi.org/10.1016/j.ajo.2014.02.009.</mixed-citation><mixed-citation xml:lang="en">Furlanetto RL, De Moraes CG, Teng CC, et al. Low-Pressure Glaucoma Treatment Study Group. Risk factors for optic disc hemorrhage in the low-pressure glaucoma treatment study. Am J Ophthalmol 2014; 157(5):945-952. https://doi.org/10.1016/j.ajo.2014.02.009.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Lee EJ, Kim TW, Kim M, et al. Recent structural alteration of the peripheral lamina cribrosa near the location of disc hemorrhage in glaucoma. Invest Ophthalmol Vis Sci 2014; 55(4):2805-2815. https://doi.org/10.1167/iovs.13-12742.</mixed-citation><mixed-citation xml:lang="en">Lee EJ, Kim TW, Kim M, et al. Recent structural alteration of the peripheral lamina cribrosa near the location of disc hemorrhage in glaucoma. Invest Ophthalmol Vis Sci 2014; 55(4):2805-2815. https://doi.org/10.1167/iovs.13-12742.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Omodaka K, Horii T, Takahashi S, et al. 3D evaluation of the lamina cribrosa with swept-source optical coherence tomography in normal tension glaucoma. PLoS One 2015; 10(4):e0122347 https://doi.org/10.1371/journal.pone.0122347.</mixed-citation><mixed-citation xml:lang="en">Omodaka K, Horii T, Takahashi S, et al. 3D evaluation of the lamina cribrosa with swept-source optical coherence tomography in normal tension glaucoma. PLoS One 2015; 10(4):e0122347 https://doi.org/10.1371/journal.pone.0122347.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Kwun Y, Han JC, Kee C. Comparison of lamina cribrosa thickness in normal tension glaucoma patients with unilateral visual field defect. Am J Ophthalmol 2015; 159(3):512-8.e1. https://doi.org/10.1016/j.ajo.2014.11.034</mixed-citation><mixed-citation xml:lang="en">Kwun Y, Han JC, Kee C. Comparison of lamina cribrosa thickness in normal tension glaucoma patients with unilateral visual field defect. Am J Ophthalmol 2015; 159(3):512-8.e1. https://doi.org/10.1016/j.ajo.2014.11.034</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Villarruel JM, Li XQ, Bach-Holm D, Hamann S. Anterior lamina cribrosa surface position in idiopathic intracranial hypertension and glaucoma. Eur J Ophthalmol 2017; 27(1):55-61. https://doi.org/10.5301/ejo.5000806.</mixed-citation><mixed-citation xml:lang="en">Villarruel JM, Li XQ, Bach-Holm D, Hamann S. Anterior lamina cribrosa surface position in idiopathic intracranial hypertension and glaucoma. Eur J Ophthalmol 2017; 27(1):55-61. https://doi.org/10.5301/ejo.5000806.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Kim YW, Jeoung JW, Girard MJ, et al. Positional and Curvature Difference of Lamina Cribrosa According to the Baseline Intraocular Pressure in Primary Open-Angle Glaucoma: A Swept-Source Optical Coherence Tomography (SS-OCT) Study. PLoS One 2016; 11(9):e0162182. https://doi.org/10.1371/journal.pone</mixed-citation><mixed-citation xml:lang="en">Kim YW, Jeoung JW, Girard MJ, et al. Positional and Curvature Difference of Lamina Cribrosa According to the Baseline Intraocular Pressure in Primary Open-Angle Glaucoma: A Swept-Source Optical Coherence Tomography (SS-OCT) Study. PLoS One 2016; 11(9):e0162182. https://doi.org/10.1371/journal.pone</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Kim M, Bojikian KD, Slabaugh MA, et al. Lamina depth and thickness correlate with glaucoma severity. Indian J Ophthalmol 2016; 64(5):358-363. https://doi.org/10.4103/0301-4738.185594.</mixed-citation><mixed-citation xml:lang="en">Kim M, Bojikian KD, Slabaugh MA, et al. Lamina depth and thickness correlate with glaucoma severity. Indian J Ophthalmol 2016; 64(5):358-363. https://doi.org/10.4103/0301-4738.185594.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Andrade JCF, Kanadani FN, Furlanetto RL, Lopes FS, Ritch R, Prata TS. Elucidation of the role of the lamina cribrosa in glaucoma using optical coherence tomography. Surv Ophthalmol 2022; 67(1):197-216. https://doi.org/10.1016/j.survophthal.2021.01.015.</mixed-citation><mixed-citation xml:lang="en">Andrade JCF, Kanadani FN, Furlanetto RL, Lopes FS, Ritch R, Prata TS. Elucidation of the role of the lamina cribrosa in glaucoma using optical coherence tomography. Surv Ophthalmol 2022; 67(1):197-216. https://doi.org/10.1016/j.survophthal.2021.01.015.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Ko Eun Kim, Ki-Ho Park. Update on the Prevalence, Etiology, Diagnosis, and Monitoring of Normal-Tension Glaucoma. Asia-Pacific Journal of Ophthalmology 2016; 5(1):23-31. https://doi.org/10.1097/APO.0000000000000177.</mixed-citation><mixed-citation xml:lang="en">Ko Eun Kim, Ki-Ho Park. Update on the Prevalence, Etiology, Diagnosis, and Monitoring of Normal-Tension Glaucoma. Asia-Pacific Journal of Ophthalmology 2016; 5(1):23-31. https://doi.org/10.1097/APO.0000000000000177.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Betzler BK, Siat DJY, Agrawal R, et al. Comparison of Peripapillary Choroidal Thickness Between Primary Open-angle Glaucoma, Normal Tension Glaucoma, and Normal Eyes: A Systematic Review and Metaanalysis. Ophthalmol Glaucoma 2024; S2589-4196(24)00035-8. https://doi.org/10.1016/j.ogla.2024.02.008.</mixed-citation><mixed-citation xml:lang="en">Betzler BK, Siat DJY, Agrawal R, et al. Comparison of Peripapillary Choroidal Thickness Between Primary Open-angle Glaucoma, Normal Tension Glaucoma, and Normal Eyes: A Systematic Review and Metaanalysis. Ophthalmol Glaucoma 2024; S2589-4196(24)00035-8. https://doi.org/10.1016/j.ogla.2024.02.008.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Jung YH, Park HY, Jung KI, Park CK. Comparison of prelaminar thickness between primary open angle glaucoma and normal tension glaucoma patients. PLoS One 2015; 10(3):e0120634. https://doi.org/10.1371/journal.pone.0120634.</mixed-citation><mixed-citation xml:lang="en">Jung YH, Park HY, Jung KI, Park CK. Comparison of prelaminar thickness between primary open angle glaucoma and normal tension glaucoma patients. PLoS One 2015; 10(3):e0120634. https://doi.org/10.1371/journal.pone.0120634.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Lopilly Park HY, Lee NY, Choi JA, Park CK. Measurement of scleral thickness using swept-source optical coherence tomography in patients with open-angle glaucoma and myopia. Am J Ophthalmol 2014; 157(4):876-84. https://doi.org/10.1016/j.ajo.2014.01.007.</mixed-citation><mixed-citation xml:lang="en">Lopilly Park HY, Lee NY, Choi JA, Park CK. Measurement of scleral thickness using swept-source optical coherence tomography in patients with open-angle glaucoma and myopia. Am J Ophthalmol 2014; 157(4):876-84. https://doi.org/10.1016/j.ajo.2014.01.007.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Wang YM, Shen R, Lin TPH, et al. Optical coherence tomography angiography metrics predict normal tension glaucoma progression. Acta Ophthalmol 2022; 100(7):e1455-e1462. https://doi.org/10.1111/aos.15117.</mixed-citation><mixed-citation xml:lang="en">Wang YM, Shen R, Lin TPH, et al. Optical coherence tomography angiography metrics predict normal tension glaucoma progression. Acta Ophthalmol 2022; 100(7):e1455-e1462. https://doi.org/10.1111/aos.15117.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Азнабаев Б.М., Загидуллина А.Ш., Александров А.А., и др. Осо- бенности микроциркуляции и морфометрии диска зрительного нерва у больных глаукомой низкого давления. РМЖ Клиническая офтальмология 2017; 17(1):17-20. https://doi.org/10.21689/2311-7729-2017-17-1-17-20</mixed-citation><mixed-citation xml:lang="en">Aznabaev B.M., Zagidullina A.Sh., Aleksandrov A.A. et al. Optic nerve head microcirculation and morphometry in normal-tension glaucoma. RMJ Clinical ophthalmology 2017; 17(1):17-20. https://doi.org/10.21689/2311-7729-2017-17-1-17-20</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">van Eijgen J, Heintz A, van der Pluijm C, et al. Normal tension glaucoma: A dynamic optical coherence tomography angiography study. Front Med (Lausanne) 2023; 9:1037471. https://doi.org/10.3389/fmed.2022.1037471.</mixed-citation><mixed-citation xml:lang="en">van Eijgen J, Heintz A, van der Pluijm C, et al. Normal tension glaucoma: A dynamic optical coherence tomography angiography study. Front Med (Lausanne) 2023; 9:1037471. https://doi.org/10.3389/fmed.2022.1037471.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Cvenkel B, Kolko M. Current Medical Therapy and Future Trends in the Management of Glaucoma Treatment. J Ophthalmol 2020; 2020:6138132. https://doi.org/10.1155/2020/6138132.</mixed-citation><mixed-citation xml:lang="en">Cvenkel B, Kolko M. Current Medical Therapy and Future Trends in the Management of Glaucoma Treatment. J Ophthalmol 2020; 2020:6138132. https://doi.org/10.1155/2020/6138132.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Wang T, Cao L, Jiang Q, Zhang T. Topical Medication Therapy for Glaucoma and Ocular Hypertension. Front Pharmacol 2021; 12:749858. https://doi.org/10.3389/fphar.2021.749858</mixed-citation><mixed-citation xml:lang="en">Wang T, Cao L, Jiang Q, Zhang T. Topical Medication Therapy for Glaucoma and Ocular Hypertension. Front Pharmacol 2021; 12:749858. https://doi.org/10.3389/fphar.2021.749858</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Takagi Y, Santo K, Hashimoto M, Fukuchi T. Ocular hypotensive effects of prostaglandin analogs in Japanese patients with normal-tension glaucoma: a literature review. Clin Ophthalmol 2018; 12:1837-1844. https://doi.org/10.2147/OPTH.S166657</mixed-citation><mixed-citation xml:lang="en">Takagi Y, Santo K, Hashimoto M, Fukuchi T. Ocular hypotensive effects of prostaglandin analogs in Japanese patients with normal-tension glaucoma: a literature review. Clin Ophthalmol 2018; 12:1837-1844. https://doi.org/10.2147/OPTH.S166657</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Kim JM, Sung KR, Kim HK, et al. Long-Term Effectiveness and Safety of Tafluprost, Travoprost, and Latanoprost in Korean Patients with Primary Open-Angle Glaucoma or Normal-Tension Glaucoma: A Multicenter Retrospective Cohort Study (LOTUS Study). J Clin Med 2021; 10(12):2717. https://doi.org/10.3390/jcm10122717</mixed-citation><mixed-citation xml:lang="en">Kim JM, Sung KR, Kim HK, et al. Long-Term Effectiveness and Safety of Tafluprost, Travoprost, and Latanoprost in Korean Patients with Primary Open-Angle Glaucoma or Normal-Tension Glaucoma: A Multicenter Retrospective Cohort Study (LOTUS Study). J Clin Med 2021; 10(12):2717. https://doi.org/10.3390/jcm10122717</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Курышева Н.И., Ким В.Е., Плиева Х.М., Ким В.Ю. Глаукома низ- кого давления: эпидемиология, патогенез, диагностика и лече- ние. Обзор литературы. Часть 2. Роль сосудистой дисрегуляции и хориокапиллярного кровотока в патогенезе. Лечение. Офтальмология 2023; 20(4):585-592. https://doi.org/10.18008/1816-5095-2023-4-585-592</mixed-citation><mixed-citation xml:lang="en">Kurysheva N.I., Kim V.E., Plieva H.M., Kim V.Yu. Normal-Tension Glaucoma: Epidemiology, Pathogenesis, Diagnosis and Treatment. Literature Review. Part 2. Role of Vascular Dysregulation in the Pathogenesis. Treatment of Normal Tension Glaucoma. Ophthalmology in Russia 2023; 20(4):585-592. https://doi.org/10.18008/1816-5095-2023-4-585-592</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Salvetat ML, Pellegrini F, Spadea L, Salati C, Zeppieri M. Pharmaceutical Approaches to Normal Tension Glaucoma. Pharmaceuticals (Basel) 2023; 16(8):1172. https://doi.org/10.3390/ph16081172</mixed-citation><mixed-citation xml:lang="en">Salvetat ML, Pellegrini F, Spadea L, Salati C, Zeppieri M. Pharmaceutical Approaches to Normal Tension Glaucoma. Pharmaceuticals (Basel) 2023; 16(8):1172. https://doi.org/10.3390/ph16081172</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Wang T, Cao L, Jiang Q, Zhang T. Topical Medication Therapy for Glaucoma and Ocular Hypertension. Front Pharmacol 2021; 12:749858. https://doi.org/10.3389/fphar.2021.749858</mixed-citation><mixed-citation xml:lang="en">Wang T, Cao L, Jiang Q, Zhang T. Topical Medication Therapy for Glaucoma and Ocular Hypertension. Front Pharmacol 2021; 12:749858. https://doi.org/10.3389/fphar.2021.749858</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Lindsey JD, Duong-Polk KX, Hammond D, Chindasub P, Leung CK, Weinreb RN. Differential protection of injured retinal ganglion cell dendrites by brimonidine. Invest Ophthalmol Vis Sci 2015; 56(3):1789- 1804. https://doi.org/10.1167/iovs.14-13892.</mixed-citation><mixed-citation xml:lang="en">Lindsey JD, Duong-Polk KX, Hammond D, Chindasub P, Leung CK, Weinreb RN. Differential protection of injured retinal ganglion cell dendrites by brimonidine. Invest Ophthalmol Vis Sci 2015; 56(3):1789- 1804. https://doi.org/10.1167/iovs.14-13892.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Komori S, Ishida K, Yamamoto T. Results of long-term monitoring of normal-tension glaucoma patients receiving medical therapy: results of an 18-year follow-up. Graefes Arch Clin Exp Ophthalmol 2014; 252(12):1963-1970. https://doi.org/10.1007/s00417-014-2767-3.</mixed-citation><mixed-citation xml:lang="en">Komori S, Ishida K, Yamamoto T. Results of long-term monitoring of normal-tension glaucoma patients receiving medical therapy: results of an 18-year follow-up. Graefes Arch Clin Exp Ophthalmol 2014; 252(12):1963-1970. https://doi.org/10.1007/s00417-014-2767-3.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Kim TW, Kim M, Lee EJ, Jeoung JW, Park KH. Intraocular pressurelowering efficacy of dorzolamide/timolol fixed combination in normal- tension glaucoma. J Glaucoma 2014; 23(5):329-332. https://doi.org/10.1097/IJG.0b013e3182741f4d.</mixed-citation><mixed-citation xml:lang="en">Kim TW, Kim M, Lee EJ, Jeoung JW, Park KH. Intraocular pressurelowering efficacy of dorzolamide/timolol fixed combination in normal- tension glaucoma. J Glaucoma 2014; 23(5):329-332. https://doi.org/10.1097/IJG.0b013e3182741f4d.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Kim JM, Kim TW, Kim CY, Kim HK,Park KH. Comparison of the intraocular pressure-lowering effect and safety of brimonidine/timolol fixed combination and 0.5 % timolol in normal-tension glaucoma patients. Jpn J Ophthalmol 2016; 60(1):20-26. https://doi.org/10.1007/s10384-015-0420-2.</mixed-citation><mixed-citation xml:lang="en">Kim JM, Kim TW, Kim CY, Kim HK,Park KH. Comparison of the intraocular pressure-lowering effect and safety of brimonidine/timolol fixed combination and 0.5 % timolol in normal-tension glaucoma patients. Jpn J Ophthalmol 2016; 60(1):20-26. https://doi.org/10.1007/s10384-015-0420-2.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Yoshikawa K, Mizoue S, Nitta K, et al. Stratification-Based Investigation of Adjunctive Brimonidine or Timolol to a Prostaglandin Analogue in Japanese Patients with Normal-Tension Glaucoma. Clin Ophthalmol 2021; 15:2875-2883. https://doi.org/10.2147/OPTH.S318392</mixed-citation><mixed-citation xml:lang="en">Yoshikawa K, Mizoue S, Nitta K, et al. Stratification-Based Investigation of Adjunctive Brimonidine or Timolol to a Prostaglandin Analogue in Japanese Patients with Normal-Tension Glaucoma. Clin Ophthalmol 2021; 15:2875-2883. https://doi.org/10.2147/OPTH.S318392</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Kuo CY, Liu CJ. Neuroprotection in Glaucoma: Basic Aspects and Clinical Relevance. J Pers Med 2022; 12(11):1884. https://doi.org/10.3390/jpm12111884.</mixed-citation><mixed-citation xml:lang="en">Kuo CY, Liu CJ. Neuroprotection in Glaucoma: Basic Aspects and Clinical Relevance. J Pers Med 2022; 12(11):1884. https://doi.org/10.3390/jpm12111884.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Weinreb RN, Liebmann JM, Cioffi GA, Goldberg I, Brandt JD, Johnson CA, et al. Oral memantine for the treatment of glaucoma: Design and results of 2 randomized, placebo-controlled, phase 3 studies. Ophthalmology 2018; 125:1874-1885. https://doi.org/10.1016/j.ophtha.2018.06.017.</mixed-citation><mixed-citation xml:lang="en">Weinreb RN, Liebmann JM, Cioffi GA, Goldberg I, Brandt JD, Johnson CA, et al. Oral memantine for the treatment of glaucoma: Design and results of 2 randomized, placebo-controlled, phase 3 studies. Ophthalmology 2018; 125:1874-1885. https://doi.org/10.1016/j.ophtha.2018.06.017.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Малишевская Т.Н., Долгова И.Г. Возможности коррекции эндоте- лиальной дисфункции оксидативного стресса у пациентов с первичной открытоугольной глаукомой. Вестник офтальмологии 2014; 130(5):6773.</mixed-citation><mixed-citation xml:lang="en">Malishevskaia TN, Dolgova IG. Options for correction of endothelial dysfunction and oxidative stress in patients with primary open-angle glaucoma. Russian Annals of Ophthalmology 2014; 130(5):6773.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Osborne A, Sanderson J, Martin KR. Neuroprotective effects of human mesenchymal stem cells and platelet-derived growth factor on human retinal ganglion cells. Stem Cells 2018; 36(1):65-78. https://doi.org/10.1002/stem.2722.</mixed-citation><mixed-citation xml:lang="en">Osborne A, Sanderson J, Martin KR. Neuroprotective effects of human mesenchymal stem cells and platelet-derived growth factor on human retinal ganglion cells. Stem Cells 2018; 36(1):65-78. https://doi.org/10.1002/stem.2722.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Vishwaraj CR, Kavitha S, Venkatesh R, Shukla AG, Chandran P, Tripathi S. Neuroprotection in glaucoma. Indian J Ophthalmol 2022; 70(2):380-385. https://doi.org/10.4103/ijo.IJO_1158_21.</mixed-citation><mixed-citation xml:lang="en">Vishwaraj CR, Kavitha S, Venkatesh R, Shukla AG, Chandran P, Tripathi S. Neuroprotection in glaucoma. Indian J Ophthalmol 2022; 70(2):380-385. https://doi.org/10.4103/ijo.IJO_1158_21.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Sena DF, Lindsley K. Neuroprotection for treatment of glaucoma in adults. Cochrane Database Syst Rev 2017; 1(1):CD006539. https://doi.org/10.1002/14651858.CD006539.pub4.</mixed-citation><mixed-citation xml:lang="en">Sena DF, Lindsley K. Neuroprotection for treatment of glaucoma in adults. Cochrane Database Syst Rev 2017; 1(1):CD006539. https://doi.org/10.1002/14651858.CD006539.pub4.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Song D., Wang L. Cost-utility analysis of treating mild stage normal tension glaucoma by surgery in China: a decision-analytic Markov model. Cost Eff Resour Alloc 2024; 22(1):13. https://doi.org/10.1186/s12962-024-00523-6.</mixed-citation><mixed-citation xml:lang="en">Song D., Wang L. Cost-utility analysis of treating mild stage normal tension glaucoma by surgery in China: a decision-analytic Markov model. Cost Eff Resour Alloc 2024; 22(1):13. https://doi.org/10.1186/s12962-024-00523-6.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Aoyama A., Ishida K., Sawada A., Yamamoto T. Target intraocular pressure for stability of visual field loss progression in normal-tension glaucoma. Jpn J Ophthalmol 2010; 54(2):117-123. https://doi.org/10.1007/s10384-009-0779-z.</mixed-citation><mixed-citation xml:lang="en">Aoyama A., Ishida K., Sawada A., Yamamoto T. Target intraocular pressure for stability of visual field loss progression in normal-tension glaucoma. Jpn J Ophthalmol 2010; 54(2):117-123. https://doi.org/10.1007/s10384-009-0779-z.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Wang SY, Singh K. Management of the glaucoma patient progressing at low normal intraocular pressure. Curr Opin Ophthalmol 2020; 31(2):107-113. https://doi.org/10.1097/ICU.0000000000000640.</mixed-citation><mixed-citation xml:lang="en">Wang SY, Singh K. Management of the glaucoma patient progressing at low normal intraocular pressure. Curr Opin Ophthalmol 2020; 31(2):107-113. https://doi.org/10.1097/ICU.0000000000000640.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Витков А.А., Куроедов А.В., Макарова А.С., Полева Р.П., Дорофеев Д.А., Асиновскова И.И. Повторная хирургия глаукомы: современный взгляд на проблему. Национальный журнал глаукома 2023; 22(4):80-88. https://doi.org/10.53432/2078-4104-2023-22-4-80-88</mixed-citation><mixed-citation xml:lang="en">Vitkov A.A., Kuroyedov A.V., Makarova A.S., Poleva R.P., Dorofeev D.A., Asinovskova I.I. Repeat glaucoma surgery: modern view of the problem. National Journal glaucoma 2023; 22(4):80-88. https://doi.org/10.53432/2078-4104-2023-22-4-80-88</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Jayaram H., Strouthidis N.G., Kamal D.S. Trabeculectomy for normal tension glaucoma: outcomes using the Moorfields Safer Surgery technique. Br J Ophthalmol 2016; 100(3):332-338. https://doi.org/10.1136/bjophthalmol-2015-306872.</mixed-citation><mixed-citation xml:lang="en">Jayaram H., Strouthidis N.G., Kamal D.S. Trabeculectomy for normal tension glaucoma: outcomes using the Moorfields Safer Surgery technique. Br J Ophthalmol 2016; 100(3):332-338. https://doi.org/10.1136/bjophthalmol-2015-306872.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Schultz SK, Iverson SM, Shi W, Greenfield DS. Safety and efficacy of achieving single-digit intraocular pressure targets with filtration surgery in eyes with progressive normal-tension glaucoma. J Glaucoma 2016; 25(2):217-222. https://doi.org/10.1097/IJG.0000000000000145.</mixed-citation><mixed-citation xml:lang="en">Schultz SK, Iverson SM, Shi W, Greenfield DS. Safety and efficacy of achieving single-digit intraocular pressure targets with filtration surgery in eyes with progressive normal-tension glaucoma. J Glaucoma 2016; 25(2):217-222. https://doi.org/10.1097/IJG.0000000000000145.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Lai C., Shao S.C., Chen Y.H., Kuo Y.K., Lai C.C., Chuang L.H. Trabeculectomy With Antimetabolite Agents for Normal Tension Glaucoma: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2022; 9:932232. https://doi.org/10.3389/fmed.2022.932232.</mixed-citation><mixed-citation xml:lang="en">Lai C., Shao S.C., Chen Y.H., Kuo Y.K., Lai C.C., Chuang L.H. Trabeculectomy With Antimetabolite Agents for Normal Tension Glaucoma: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2022; 9:932232. https://doi.org/10.3389/fmed.2022.932232.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Nakajima K., Sakata R., Ueda K., Fujita A., Fujishiro T., Honjo M., et al. Central visual field change after fornix-based trabeculectomy in Japanese normal-tension glaucoma patients managed under 15 mmHg. Graefes Arch Clin Exp Ophthalmol 2021; 259(8):2309-2316. https://doi.org/10.1007/s00417-021-05215-y.</mixed-citation><mixed-citation xml:lang="en">Nakajima K., Sakata R., Ueda K., Fujita A., Fujishiro T., Honjo M., et al. Central visual field change after fornix-based trabeculectomy in Japanese normal-tension glaucoma patients managed under 15 mmHg. Graefes Arch Clin Exp Ophthalmol 2021; 259(8):2309-2316. https://doi.org/10.1007/s00417-021-05215-y.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Suominen S, Harju M, Kurvinen L, Vesti E. Deep sclerectomy in normal- tension glaucoma with and without mitomycin-c. Acta Ophthalmol 2014; 92(7):701-706. https://doi.org/10.1111/aos.12305.</mixed-citation><mixed-citation xml:lang="en">Suominen S, Harju M, Kurvinen L, Vesti E. Deep sclerectomy in normal-tension glaucoma with and without mitomycin-c. Acta Ophthalmol 2014; 92(7):701-706. https://doi.org/10.1111/aos.12305.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Gabai A., Cimarosti R., Battistella C., Isola M., Lanzetta P. Efficacy and Safety of Trabeculectomy Versus Nonpenetrating Surgeries in Openangle Glaucoma: A Meta-analysis. J Glaucoma 2019; 28(9):823-833. https://doi.org/10.1097/IJG.0000000000001323.</mixed-citation><mixed-citation xml:lang="en">Gabai A., Cimarosti R., Battistella C., Isola M., Lanzetta P. Efficacy and Safety of Trabeculectomy Versus Nonpenetrating Surgeries in Openangle Glaucoma: A Meta-analysis. J Glaucoma 2019; 28(9):823-833. https://doi.org/10.1097/IJG.0000000000001323.</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Еричев В.П., Асратян Г.К. Микрошунтирование как стартовое хирургическое вмешательство при первичной глаукоме. РМЖ Клиническая офтальмология 2014; 14(2):76-78</mixed-citation><mixed-citation xml:lang="en">Erichev V.P., Asratyan G.K. Micro stenting as a first surgery for primary glaucoma. RMJ Clinical Ophthalmology 2014; 14(2):76-78.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Аветисов С.Э., Еричев В.П., Асратян Г.К. Микрошунтирование в хирургии глаукомы в артифакичных глазах. Национальный журнал глаукома 2013; 3-1:44-47.</mixed-citation><mixed-citation xml:lang="en">Avetisov S.E, Erichev V.P., Asratyan G.K. Microshunting in glaucoma surgery in artiphakic eyes. Natsional’nyi zhurnal glaukoma 2013; 3-1:44-47.</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Еричев В.П., Асратян Г.К. Эффективность и безопасность микрошунтирования в хирургии первичной глаукомы. Глаукома. Журнал НИИ ГБ РАМН 2012; 4:50-53.</mixed-citation><mixed-citation xml:lang="en">Erichev V.P., Asratyan G.K. Efficacy and safety of microshunting in primary glaucoma surgery. Glaukoma. Zhurnal NII GB RAMN 2012; 4: 50-53.</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Еричев В.П., Асратян Г.К. Минишунтирование в хирургии глаукомы. Глаукома 2012; 2:66-71.</mixed-citation><mixed-citation xml:lang="en">Yerichev V.P., Asratyan G.K. Mini-shunting in glaucoma surgery. Glaucoma 2012; 2:66-71.</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Hashimoto Y., Michihata N., Matsui H., Fushimi K., Yasunaga H., Aihara M. Reoperation rates after Ex-PRESS versus trabeculectomy for primary open-angle or normal-tension glaucoma: a national database study in Japan. Eye (Lond) 2020; 34(6):1069-1076. https://doi.org/10.1038/s41433-019-0641-6.</mixed-citation><mixed-citation xml:lang="en">Hashimoto Y., Michihata N., Matsui H., Fushimi K., Yasunaga H., Aihara M. Reoperation rates after Ex-PRESS versus trabeculectomy for primary open-angle or normal-tension glaucoma: a national database study in Japan. Eye (Lond) 2020; 34(6):1069-1076. https://doi.org/10.1038/s41433-019-0641-6.</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Hallaj S, Wong JC, Hock LE, Kolomeyer NN, Shukla AG, Pro MJ, Moster MR, Myers JS, Razeghinejad R, Lee D. Long-Term Surgical Outcomes of Glaucoma Drainage Implants in Eyes with Preoperative Intraocular Pressure Less than 19 mmHg. J Ophthalmol 2024; 2024:6624021. https://doi.org/10.1155/2024/6624021.</mixed-citation><mixed-citation xml:lang="en">Hallaj S, Wong JC, Hock LE, Kolomeyer NN, Shukla AG, Pro MJ, Moster MR, Myers JS, Razeghinejad R, Lee D. Long-Term Surgical Outcomes of Glaucoma Drainage Implants in Eyes with Preoperative Intraocular Pressure Less than 19 mmHg. J Ophthalmol 2024; 2024:6624021. https://doi.org/10.1155/2024/6624021.</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Schargus M., Theilig T., Rehak M., Busch C., Bormann C., Unterlauft J.D. Outcome of a single XEN microstent implant for glaucoma patients with different types of glaucoma. BMC Ophthalmol 2020; 20(1):490. https://doi.org/10.1186/s12886-020-01764-8.</mixed-citation><mixed-citation xml:lang="en">Schargus M., Theilig T., Rehak M., Busch C., Bormann C., Unterlauft J.D. Outcome of a single XEN microstent implant for glaucoma patients with different types of glaucoma. BMC Ophthalmol 2020; 20(1):490. https://doi.org/10.1186/s12886-020-01764-8.</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Chang E.K., Gupta S., Chachanidze M., Hall N., Chang T.C., Sola-Del Valle D. Safety and efficacy of microinvasive glaucoma surgery with cataract extraction in patients with normal-tension glaucoma. Sci Rep 2021; 11(1):8910. https://doi.org/10.1038/s41598-021-88358-6.</mixed-citation><mixed-citation xml:lang="en">Chang E.K., Gupta S., Chachanidze M., Hall N., Chang T.C., Sola-Del Valle D. Safety and efficacy of microinvasive glaucoma surgery with cataract extraction in patients with normal-tension glaucoma. Sci Rep 2021; 11(1):8910. https://doi.org/10.1038/s41598-021-88358-6.</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Oo H.H., Hong A.S.Y., Lim S.Y., Ang B.C.H. Angle-based minimally invasive glaucoma surgery in normal tension glaucoma: A systematic review and meta-analysis. Clin Exp Ophthalmol 2024; 52(7):740-760. https://doi.org/10.1111/ceo.14408.</mixed-citation><mixed-citation xml:lang="en">Oo H.H., Hong A.S.Y., Lim S.Y., Ang B.C.H. Angle-based minimally invasive glaucoma surgery in normal tension glaucoma: A systematic review and meta-analysis. Clin Exp Ophthalmol 2024; 52(7):740-760. https://doi.org/10.1111/ceo.14408.</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Kuerten D., Walter P., Baumgarten S., Fuest M., Plange N. 12-month outcomes of ab interno excisional goniotomy combined with cataract surgery in primary open-angle glaucoma and normal tension glaucoma. Int Ophthalmol 2023; 43(8):2605-2612. https://doi.org/10.1007/s10792-023-02659-5.</mixed-citation><mixed-citation xml:lang="en">Kuerten D., Walter P., Baumgarten S., Fuest M., Plange N. 12-month outcomes of ab interno excisional goniotomy combined with cataract surgery in primary open-angle glaucoma and normal tension glaucoma. Int Ophthalmol 2023; 43(8):2605-2612. https://doi.org/10.1007/s10792-023-02659-5.</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Clement C., Howes F., Ioannidis A.S., Shiu M., Manning D., Lusthaus J., et al. Two-Year Multicenter Outcomes of iStent inject Trabecular Micro-Bypass Stents Combined with Phacoemulsification in Various Types of Glaucoma and Ocular Hypertension. Clin Ophthalmol 2020; 14:3507-3517. https://doi.org/10.2147/OPTH.S271646.</mixed-citation><mixed-citation xml:lang="en">Clement C., Howes F., Ioannidis A.S., Shiu M., Manning D., Lusthaus J., et al. Two-Year Multicenter Outcomes of iStent inject Trabecular Micro-Bypass Stents Combined with Phacoemulsification in Various Types of Glaucoma and Ocular Hypertension. Clin Ophthalmol 2020; 14:3507-3517. https://doi.org/10.2147/OPTH.S271646.</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Benekos K., Katsanos A., Haidich A.B., Dastiridou A., Nikolaidou A., Konstas A.G. The Effect of Phacoemulsification on the Intraocular Pressure of Patients with Open-angle Glaucoma: A Systematic Review and Meta-Analysis. J Glaucoma 2024; 33(8):576-586. https://doi.org/10.1097/IJG.0000000000002386.</mixed-citation><mixed-citation xml:lang="en">Benekos K., Katsanos A., Haidich A.B., Dastiridou A., Nikolaidou A., Konstas A.G. The Effect of Phacoemulsification on the Intraocular Pressure of Patients with Open-angle Glaucoma: A Systematic Review and Meta-Analysis. J Glaucoma 2024; 33(8):576-586. https://doi.org/10.1097/IJG.0000000000002386.</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Gillmann K, Hornbeak DM. Rates of visual field change and functional progression in glaucoma following trabecular microbypass implantation of iStent technologies: a meta-analysis. BMJ Open Ophthalmol 2024; 9(1):e001575. https://doi.org/10.1136/bmjophth-2023-001575</mixed-citation><mixed-citation xml:lang="en">Gillmann K, Hornbeak DM. Rates of visual field change and functional progression in glaucoma following trabecular microbypass implantation of iStent technologies: a meta-analysis. BMJ Open Ophthalmol 2024; 9(1):e001575. https://doi.org/10.1136/bmjophth-2023-001575</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
